/주식/QNCX
QNCX

QNCX

USD

Quince Therapeutics Inc. Common Stock

$1.600+0.040 (2.564%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$1.560

고가

$1.620

저가

$1.555

거래량

0.11M

기업 기본 정보

시가총액

85.9M

산업

생명공학

국가

United States

거래 통계

평균 거래량

0.27M

거래소

NMS

통화

USD

52주 범위

저가 $0.72현재가 $1.600고가 $2.45

관련 뉴스

BusinessWire

Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting

Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced the poster presentation of

더 보기
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting
Analyst Upgrades

D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $4 Price Target

D. Boral Capital analyst Jason Kolbert maintains Quince Therapeutics with a Buy and maintains $4 price target.

더 보기
D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $4 Price Target
BusinessWire

Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study

Quince Therapeutics, Inc.

더 보기
Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study